AI Portfolio Summary
In 2025 Q4, Iron Triangle Partners LP maintained a portfolio of 41 distinct positions. The most significant new addition to the portfolio was INTUITIVE SURGICAL I, which now represents 6.12% of the total fund value. They heavily accumulated shares in CHARLES RIV LABS INT, increasing their position by 41.7%. Conversely, Iron Triangle Partners LP completely exited their position in DEXCOM INC.
Total Positions
41
Quarter
2025 Q4
Top Holding
CRL (8.7%)
Top 10 Concentration
53.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 41
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CRL
CHARLES RIV LAB...
|
Healthcare | 8.66% | 5.96% |
#1
4
Prev: #5
|
5.6 | 111,728 | 41.7% |
P
S
|
379,728 | $75,748,141 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 6.12% | — |
#2
Prev: #—
|
4.4 | 94,459 | no change |
NEW
|
94,459 | $53,497,799 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 6.00% | 5.13% |
#3
5
Prev: #8
|
4.5 | 50,474 | 18.7% |
P
S
|
320,474 | $52,512,870 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 5.68% | 2.81% |
#4
13
Prev: #17
|
4.6 | 142,170 | 94.8% |
P
S
|
292,170 | $49,668,900 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VCYT
VERACYTE INC
|
Healthcare | 4.72% | 2.37% |
#5
16
Prev: #21
|
4.2 | 495,391 | 102.1% |
P
S
|
980,391 | $41,274,461 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 4.59% | — |
#6
Prev: #—
|
3.8 | 420,773 | no change |
NEW
|
420,773 | $40,120,706 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WAT
WATERS CORP
|
Healthcare | 4.57% | — |
#7
Prev: #—
|
3.8 | 105,167 | no change |
NEW
|
105,167 | $39,945,582 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BKD
BROOKDALE SR LI...
|
Healthcare | 4.31% | 3.42% |
#8
7
Prev: #15
|
3.8 | 653,302 | 23.0% |
P
S
|
3,491,663 | $37,675,044 | 2020 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 4.31% | 5.38% |
#9
3
Prev: #6
|
1.8 | -14,510 | -29.3% |
P
S
|
35,045 | $37,662,161 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BRKR
BRUKER CORP
|
Healthcare | 4.28% | — |
#10
Prev: #—
|
3.7 | 794,380 | no change |
NEW
|
794,380 | $37,423,242 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 3.99% | — |
#11
Prev: #—
|
3.6 | 76,910 | no change |
NEW
|
76,910 | $34,867,918 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 3.92% | 8.55% |
#12
11
Prev: #1
|
1.7 | -365,443 | -45.8% |
P
S
|
432,457 | $34,319,788 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FTRE
FORTREA HLDGS I...
|
Healthcare | 3.92% | — |
#13
Prev: #—
|
3.6 | 1,986,333 | no change |
NEW
|
1,986,333 | $34,264,244 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MMSI
MERIT MED SYS I...
|
Healthcare | 3.89% | — |
#14
Prev: #—
|
3.6 | 385,660 | no change |
NEW
|
385,660 | $33,992,072 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 3.84% | 5.21% |
#15
8
Prev: #7
|
1.6 | -341,093 | -27.5% |
P
S
|
897,427 | $33,608,641 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DOCS
DOXIMITY INC
|
Healthcare | 3.48% | 2.18% |
#16
7
Prev: #23
|
3.7 | 476,568 | 226.9% |
P
S
|
686,568 | $30,401,231 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TECH
BIO-TECHNE CORP
|
Healthcare | 3.14% | — |
#17
Prev: #—
|
3.3 | 467,409 | no change |
NEW
|
467,409 | $27,488,323 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATEC
ALPHATEC HLDGS ...
|
Healthcare | 3.09% | — |
#18
Prev: #—
|
3.2 | 1,285,685 | no change |
NEW
|
1,285,685 | $27,050,812 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AHCO
ADAPTHEALTH COR...
|
Healthcare | 2.97% | 2.45% |
#19
1
Prev: #20
|
3.3 | 684,871 | 35.6% |
P
S
|
2,609,003 | $25,985,670 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NVST
ENVISTA HOLDING...
|
Healthcare | 2.95% | — |
#20
Prev: #—
|
3.2 | 1,186,704 | no change |
NEW
|
1,186,704 | $25,763,344 | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 2.65% | — |
#21
Prev: #—
|
3.1 | 70,126 | no change |
NEW
|
70,126 | $23,149,294 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABT
ABBOTT LABS
|
Healthcare | 2.51% | — |
#22
Prev: #—
|
3.0 | 175,333 | no change |
NEW
|
175,333 | $21,967,472 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 1.85% | 1.04% |
#23
1
Prev: #24
|
3.0 | 197,484 | 73.1% |
P
S
|
467,484 | $16,160,922 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 1.24% | — |
#24
Prev: #—
|
2.5 | 958,336 | no change |
NEW
|
958,336 | $10,819,613 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.20% | — |
#25
Prev: #—
|
2.5 | 233,688 | no change |
NEW
|
233,688 | $10,473,896 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.00% | 8.13% |
Sold All 😨
(Was: #2) |
0.3 | -850,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABBV
ABBVIE INC
|
Healthcare | 0.00% | 6.60% |
Sold All 😨
(Was: #3) |
0.3 | -200,326 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 0.00% | 6.14% |
Sold All 😨
(Was: #4) |
0.3 | -453,347 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 0.00% | 3.98% |
Sold All 😨
(Was: #9) |
0.3 | -342,804 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
THC
TENET HEALTHCAR...
|
Healthcare | 0.00% | 3.97% |
Sold All 😨
(Was: #10) |
0.3 | -137,448 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 0.00% | 3.89% |
Sold All 😨
(Was: #11) |
0.3 | -500,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ADPT
ADAPTIVE BIOTEC...
|
Healthcare | 0.00% | 3.87% |
Sold All 😨
(Was: #12) |
0.3 | -1,820,915 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.00% | 3.81% |
Sold All 😨
(Was: #13) |
0.3 | -58,378 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 0.00% | 3.55% |
Sold All 😨
(Was: #14) |
0.3 | -400,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 0.00% | 3.08% |
Sold All 😨
(Was: #16) |
0.3 | -138,011 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 0.00% | 2.62% |
Sold All 😨
(Was: #18) |
0.3 | -131,390 | -100.0% |
CLOSED
|
— | $— | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
WST
WEST PHARMACEUT...
|
Healthcare | 0.00% | 2.61% |
Sold All 😨
(Was: #19) |
0.3 | -70,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 0.00% | 2.21% |
Sold All 😨
(Was: #22) |
0.3 | -1,971,260 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARGX
ARGENX SE
|
Healthcare | 0.00% | 1.04% |
Sold All 😨
(Was: #25) |
0.3 | -9,900 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 41 holdings